Dr. Morgan E. Tharp II, MD

Dr. Tharp practices at Adventhealth Medical Group Surgical Specialists at Wesley Chapel - HOPD in Wesley Chapel, Florida.

Dr. Tharp's NPI, 1326030362, was assigned on August 16, 2005. Dr. Tharp graduated from Indiana University School Of Medicine in 1989. Dr. Tharp holds Florida license ME154520.

Dr. Tharp's primary practice is Adventhealth Medical Group Surgical Specialists at Wesley Chapel - HOPD, at 2590 Healing Way, Wesley Chapel, FL 33543.

Dr. Tharp's primary practice is Adventhealth Medical Group Surgical Specialists at Wesley Chapel - HOPD in Wesley Chapel, Florida. Dr. Tharp is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Tharp to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tharp practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tharp's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tharp is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Tharp's licenses on file in 4 states: Florida, Indiana, Michigan and Texas.

Dmand AI lists bone cancer radiation, breast cancer radiation, lung cancer radiation, lymphoma radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Tharp treats.

CMS data shows 1,689 Medicare services from Dr. Tharp across 18 procedure codes in 2024, for 208 Medicare patients. Medicare paid $104,703 for them. Every service was in an office.

CMS counts 208 Medicare patients who saw Dr. Tharp in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tharp's median patient age at 70, with 42% women.

In 2024, Dr. Tharp wrote 155 Medicare Part D claims for 65 patients. 90% of them were for generic drugs. CMS names the drug for 87 of them, across 4 drugs with 11 or more claims each, at $2,403 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Tharp for performance year 2024, reported as part of a group. Dr. Tharp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tharp as offering telehealth.

Dmand AI links 3 papers to Dr. Tharp in 2008. The most frequent topics are Brachytherapy, Prostatic Neoplasms and Radiation Injuries. Dr. Tharp's most frequent co-authors are Jennifer M. Burns, MD and Michael C. Hardacre, MD.

CMS Open Payments shows 13 general payments to Dr. Tharp from 8 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Kyowa Kirin, Inc. paid the most, $55.

Dr. Tharp graduated from Indiana University School Of Medicine in 1989.

Dr. Tharp is in network with 11 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.